Your browser doesn't support javascript.
loading
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030.
Vogel, Birgit; Acevedo, Monica; Appelman, Yolande; Bairey Merz, C Noel; Chieffo, Alaide; Figtree, Gemma A; Guerrero, Mayra; Kunadian, Vijay; Lam, Carolyn S P; Maas, Angela H E M; Mihailidou, Anastasia S; Olszanecka, Agnieszka; Poole, Jeanne E; Saldarriaga, Clara; Saw, Jacqueline; Zühlke, Liesl; Mehran, Roxana.
Affiliation
  • Vogel B; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Acevedo M; Divisón de Enfermedades Cardiovasculares, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Appelman Y; Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands.
  • Bairey Merz CN; Barbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Chieffo A; Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Figtree GA; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Guerrero M; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
  • Kunadian V; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK; Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundations Trust, Newcastle Upon Tyne, UK.
  • Lam CSP; National Heart Centre Singapore, Singapore; Cardiovascular Sciences Academic Clinical Programme, Duke-National University of Singapore, Singapore.
  • Maas AHEM; Department of Women's Cardiac Health, Radboud University Medical Center, Nijmegen, Netherlands.
  • Mihailidou AS; Royal North Shore Hospital, Northern Sydney Local Health District, Sydney, NSW, Australia; Cardiovascular and Hormonal Research Laboratory, Kolling Institute, Sydney, NSW, Australia; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
  • Olszanecka A; 1st Department of Cardiology, Interventional Electrocardiology and Hypertension, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • Poole JE; Division of Cardiology, University of Washington Medical Center, Seattle, WA, USA.
  • Saldarriaga C; Department of Cardiology and Heart Failure Clinic, Clinica CardioVID, University of Antioquia, Medellín, Colombia.
  • Saw J; Division of Cardiology, Vancouver General Hospital, Vancouver, BC, Canada.
  • Zühlke L; Departments of Paediatrics and Medicine, Divisions of Paediatric and Adult Cardiology, Red Cross Children's and Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
  • Mehran R; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: roxana.mehran@mountsinai.org.
Lancet ; 397(10292): 2385-2438, 2021 06 19.
Article in En | MEDLINE | ID: mdl-34010613

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Women's Health / Cost of Illness / Internationality / Goals Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Lancet Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Women's Health / Cost of Illness / Internationality / Goals Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Lancet Year: 2021 Type: Article Affiliation country: United States